SERMO has had its drug ratings tool (SDR) available for over a year now and the company decided it was time to see what physicians think about the ability to get other doctors' feedback on treatments.
What they found was a population of specialists who respect and value the opinions of their peers, and are willing to change prescribing behaviors based on them.
- 84%: real world data will improve patient outcomes
- 80%: reviews will change their perception of a drug
- 77% plan on using SDR when researching drugs for patients
- 73% believe their peers more than pharma information
- 57% have already had their opinion of a drug change based on reviews
“Patients in the real world are more complex than those that participate in clinical trials. Physicians have always consulted each other for advice about the best course of therapy, relying on one another. Although clinical studies are the foundation by which physicians evaluate drugs, those studies cannot offer real world experience. Drug Ratings lets global doctors share those real-world insights at scale,” said SERMO CEO Peter Kirk.
SERMO presented this data in a webinar on Thursday, Nov 2 in conjunction with MM&M. Hopefully the video will be available for anyone who can’t make it. Sign up even if you are booked then so you get the information after the webinar.
See the full story in the SERMO press release.